Germline and somatic homologous recombination gene mutations in high-grade serous ovarian cancer and clinical outcome.

5579Background: Mutations in homologous recombination (HR) genes other than BRCA1/2 genes have been reported to cause a BRCA-like phenotype in up to 50% of HGSOC. PARP inhibitors (PARPi) are effect...